Real-time enrollment status for this lymphocytic leukemia clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 5:07 AM UTC
| NCT Number | NCT03219450 |
| Recruiting Status | Recruiting |
| Condition | Lymphocytic Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 15 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | May 28, 2026 (May 28, 2026) |
As of August 31, 2026: Clinical trial NCT03219450 is currently recruiting participants. This phase1 study for lymphocytic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03219450 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03219450 was last updated May 28, 2026 (May 28, 2026). HelloStudys verifies this status automatically.